Compile Data Set for Download or QSAR
Report error Found 11 Enz. Inhib. hit(s) with all data for entry = 11762
TargetReplicase polyprotein 1a(2019-nCoV)
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM645352(US20240016777, Table1a.2 | Maackiaflavanone)
Affinity DataIC50: 3.00E+3nMAssay Description:Assay details: A SARS-Cov-2 Mpro construct was prepared, which includes a His-tag and PreScission cleavage site (see FIG. 3A). The construct was tran...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM645355(US20240016777, Table1a.6 | 5,7,2',4'- Tetrahydroxy...)
Affinity DataIC50: 5.00E+3nMAssay Description:Assay details: A SARS-Cov-2 Mpro construct was prepared, which includes a His-tag and PreScission cleavage site (see FIG. 3A). The construct was tran...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM645353(US20240016777, Table1a.3 | Kushenol C)
Affinity DataIC50: 5.50E+3nMAssay Description:Assay details: A SARS-Cov-2 Mpro construct was prepared, which includes a His-tag and PreScission cleavage site (see FIG. 3A). The construct was tran...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM645364(US20240016777, Table3.6 | pinocembrin 7-O-(3$#8243...)
Affinity DataIC50: 6.00E+3nMAssay Description:Assay details: A SARS-Cov-2 Mpro construct was prepared, which includes a His-tag and PreScission cleavage site (see FIG. 3A). The construct was tran...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM645361(US20240016777, Table2a.1 | furowanin A)
Affinity DataIC50: 7.00E+3nMAssay Description:Assay details: A SARS-Cov-2 Mpro construct was prepared, which includes a His-tag and PreScission cleavage site (see FIG. 3A). The construct was tran...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM429466(med.21724, Compound 138 | acs.jmedchem.1c00409_ST....)
Affinity DataIC50: 8.00E+3nMAssay Description:Assay details: A SARS-Cov-2 Mpro construct was prepared, which includes a His-tag and PreScission cleavage site (see FIG. 3A). The construct was tran...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM645366(US20240016777, Table3.8 | Jaceidin triacetate)
Affinity DataIC50: 1.20E+4nMAssay Description:Assay details: A SARS-Cov-2 Mpro construct was prepared, which includes a His-tag and PreScission cleavage site (see FIG. 3A). The construct was tran...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM645360(US20240016777, Table1d.1 | Multicaulisin)
Affinity DataIC50: 1.70E+4nMAssay Description:Assay details: A SARS-Cov-2 Mpro construct was prepared, which includes a His-tag and PreScission cleavage site (see FIG. 3A). The construct was tran...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM645354(US20240016777, Table1a.5 | 8- Lavandulylkaempferol)
Affinity DataIC50: 1.95E+4nMAssay Description:Assay details: A SARS-Cov-2 Mpro construct was prepared, which includes a His-tag and PreScission cleavage site (see FIG. 3A). The construct was tran...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM645358(US20240016777, Table1a.12 | sophoraflavanone C)
Affinity DataIC50: 6.30E+4nMAssay Description:Assay details: A SARS-Cov-2 Mpro construct was prepared, which includes a His-tag and PreScission cleavage site (see FIG. 3A). The construct was tran...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2024
Entry Details
Go to US Patent

TargetReplicase polyprotein 1a(2019-nCoV)
Beth Israel Deaconess Medical Center

US Patent
LigandPNGBDBM645357(US20240016777, Table1a.8 | Euchrestaflavanone B)
Affinity DataIC50: 9.60E+4nMAssay Description:Assay details: A SARS-Cov-2 Mpro construct was prepared, which includes a His-tag and PreScission cleavage site (see FIG. 3A). The construct was tran...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2024
Entry Details
Go to US Patent